Global Epidemiology of Urinary Tract Infections
Journal Submission Sample Work
Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, affecting individuals of all ages and placing a significant burden on healthcare systems. The incidence and prevalence of UTIs vary across regions due to differences in demographics, healthcare access, hygiene practices, and antimicrobial resistance patterns. India, like many developing countries, faces increasing challenges related to recurrent UTIs and multidrug-resistant uropathogens. Understanding the global and Indian epidemiology of UTIs is essential for improving prevention, diagnosis, treatment, and public health strategies.
Urology or infectious diseases? Deciding where a UTI epidemiology review belongs
Urinary tract infections are among the most frequent bacterial infections seen in both community and hospital practice. They range from uncomplicated cystitis in otherwise healthy women to complicated, catheter-associated and recurrent infections, and pyelonephritis that can progress to urosepsis. Escherichia coli remains the dominant uropathogen, and rising resistance to commonly used oral antibiotics has made the epidemiology of UTIs inseparable from the wider problem of antimicrobial resistance. In India, high antibiotic consumption, over-the-counter access and variable laboratory capacity add to that concern.
The manuscript in this sample, Global Epidemiology of Urinary Tract Infections: An Indian and Worldwide Perspective, therefore straddles two academic communities. Its ten keywords include urology and uropathogens on one side, and antimicrobial resistance, clinical microbiology, infectious diseases and global health on the other. The journal submission report resolves the question by recommending one urology review journal and two infectious-disease journals, so the author can decide which audience to address first.
The three journals and the case made for each
- Nature Reviews Urology (Springer Nature) is put forward as the high-visibility option for a review covering the whole spectrum of urology. The example papers cited — on decision-making in bladder cancer and on rare childhood kidney tumours — show that it publishes broad, authoritative reviews, though not specifically on infection.
- Infection and Drug Resistance (Dove Medical Press) is described as an open-access journal on the treatment of bacterial, fungal, viral and parasitic infection and on strategies to limit resistance. Its examples include a risk model for post-craniotomy meningitis and a study of nontuberculous mycobacterial disease with bronchiectasis.
- BMC Infectious Diseases (BioMed Central) is presented as covering prevention, diagnosis and management of infectious and sexually transmitted diseases, together with their epidemiology. Its examples include a prevalence and genotype study of high-risk HPV in East Malaysia — a regional epidemiology paper not unlike the Indian component of the manuscript.
A short supporting table then reduces each journal to a rationale and a scope statement; for Infection and Drug Resistance, the rationale names UTI epidemiology and resistance reviews explicitly.
Side-by-side figures, as reported in the sample
The comparator collects the practical facts. Values are reproduced as the sample reports them; journal metrics and charges are revised annually and should be confirmed before submission.
| Parameter | Nat Rev Urol | Infect Drug Resist | BMC Infect Dis |
|---|---|---|---|
| Impact factor | 13.6 | 3.2 | 3.2 |
| Review duration | 6–12 weeks | 42 days | 4–8 weeks |
| Acceptance rate | 5–10% | 24% | 35% |
| APC | none (free to publish) | USD 3,650 | USD 2,850 |
| Word count | 5,000–8,000 | no strict limit | 12,000 |
| References | 50–100 | no strict cap | no strict maximum |
The publication-type row is informative: Nature Reviews Urology is listed as publishing non-primary articles only, which suits a review, while the two open-access journals accept original research, reviews and other formats.
Weighing a free review journal against open-access infection titles
The report's own appendix names Nature Reviews Urology as the best choice for a high-impact review, with the other two as strong alternatives. That judgement needs some context. Review journals in the Nature Reviews family typically commission much of their content, so an unsolicited epidemiology review would normally begin with a pre-submission enquiry, and a reported acceptance rate of 5–10% leaves little margin. The infectious-disease journals are more accessible, charge a publication fee, and reach the microbiologists and stewardship teams most likely to act on resistance data.
For a review centred on India, open access has a further advantage: clinicians and public-health staff in the settings described can read the findings without a subscription. If the manuscript systematically pools prevalence or resistance data, editors will expect PRISMA-style reporting of the search and selection process, which Pubrica supports through its clinical literature review service.
Making the most of this sample for your own submission
The eight-question appendix shows how a report can answer the questions co-authors usually raise — which journal has the highest impact factor, which are open access, whether all are indexed in PubMed, Scopus and Web of Science. When reusing the format, choose example articles that match the manuscript's topic as closely as possible; editors respond to evidence that a journal already publishes on UTIs or resistance, not just on its broad specialty. Pubrica's journal selection and journal submission services prepare and act on reports of this kind.
Questions about this sample
Why does the UTI report mix a urology journal with infectious-disease journals?
Urinary tract infections are managed by urologists but studied intensively by microbiologists and infectious-disease specialists, especially where antimicrobial resistance is concerned. The manuscript's keywords span both groups. Offering Nature Reviews Urology alongside Infection and Drug Resistance and BMC Infectious Diseases lets the author choose which readership the review should primarily serve.
Is Nature Reviews Urology really free to publish in?
The sample lists no article processing charge for Nature Reviews Urology and describes publishing as free, as reported at the time the report was prepared. The trade-off is selectivity: the sample reports an acceptance rate of 5 to 10 percent, and review journals of this type often commission articles, so a pre-submission enquiry is advisable.
Which journal does the report link most directly to antimicrobial resistance?
Infection and Drug Resistance. Its rationale in the supporting table states that it focuses on infectious diseases and antimicrobial resistance, making it suitable for UTI epidemiology and resistance reviews. As reported in the sample, its review duration is about 42 days and it places no strict limit on length, figures or references.
Should a review of UTI prevalence in India follow a reporting guideline?
If it is a systematic review that searches databases and pools prevalence or resistance estimates, PRISMA is the expected standard, including a flow diagram and clear eligibility criteria. A narrative review is less constrained, but explaining how studies were chosen still helps readers judge differences between Indian and global data.
Give yourself the academic edge today
Each order includes
- On-time delivery or your money back
- A fully qualified writer in your subject
- In-depth proofreading by our Quality Control Team
- 100% confidentiality, the work is never re-sold or published
- Standard 7-day amendment period
- A paper written to the standard ordered
- A detailed plagiarism report
- A comprehensive quality report
Enquire Now
